Lipocine (NASDAQ: LPCN) widens H1 loss but extends cash runway to 2027
Lipocine Inc. reported a Q2 2026 revenue of $190,099 and a net loss of $2.6 million, with a H1 2026 loss of $6.3 million. Despite increased operating expenses due to higher R&D, the company has extended its cash runway to August 2027 after raising …